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Esters in ADC linkers:
Optimization of stability and lysosomal cleavage
Kelsey A. Watts, Samantha R. Benjamin, Courtney P. Jackson, Brittany Brems, Siteng Fang, Tchilabolo Alayi, Yetrib Hathout, and L. Nathan Tumey

Abstract
Antibody drug conjugates (ADCs) present a unique opportunity to increase the safety of highly toxic drugs by utilizing the specificity of
antibodies to obtain targeted delivery of potent drugs to specific tissues. Classically, this is achieved by linking an amine-containing payload to
an antibody using the well-studied mcValCitPABC linker. Yet, there are surprisingly few technologies for attaching alcohol containing payloads to
an antibody. Theoretically, the simplest way to do this would be through an ester linkage. However, very little is known about the lysosomal and
plasma stability of ester linkages on ADCs. Herein, we describe a number of experiments to evaluate this stability in both human/mouse plasma
and in lysosomes. Furthermore, we describe the design of a peptide-linked ester that is rapidly cleaved in the lysosome.
The stability of ester linked payloads was evaluated by examining an anti-Her2 antibody bound to an ester linked dexamethasone
payload. In the presence of lysosomes, the ester remained intact while the antibody backbone was proteolytically degraded. Upon incubation
with SKBR3 cells, the major product released from the ADC was an ester-containing metabolite, cys-mc-Dex, thus confirming the lysosomal
stability of this linkage in a cell-based system. Having demonstrated that simple esters are stable upon lysosomal uptake,we next undertook the
design of a novel linker that undergoes immolation resulting in spontaneous ester-cleavage. In a model system designed to release
dexamethasone, we have shown that this linker is rapidly cleaved by cathepsin B, thus resulting in the release of free dexamethasone.
Furthermore, we show that the ester is stable in mouse plasma and only cleaved upon lysosomal uptake. With this research we hope to further
our knowledge of ester linkages in ADCs as well as to develop a feasible way to release an unmodified alcohol-containing drug into a chosen
cell type via a lysosomally-induced ester linkage.
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Overall Goal
Deliver a glucocorticoid to lymphocytes using targeted drug delivery via antibody in order
to increase efficacy and decrease side effects of drugs that treat autoimmune diseases
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This sterically constrained linker rapidly releases dexamethasone in the presence of the
lysosome. This could be widely useful for the release of unmodified alcohol containing
payloads.

Cell Internalization
The antibody binds to the
antigen of choice on the cell
surface. It is then absorbed into
the cell where it is trafficked to
the lysosome and the drug is
released.

Future Work

• Are the cleavable linkers stable in plasma?
• Is dexamethasone the best GC? (betamethasone?)
• Can we demonstrate selective functional activity?

Nature Biotechnology, 2012, 30, 631–637.

Release of alcohol containing payloads
Experimental payloads, dexamethasone and
everolimus, are used to simulate glucocorticoids
which typically have an alcohol handle rather
than an amine handle. There is a demand for
novel ways to release these alcohol-containing
payloads upon lysosomal uptake.
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Site-Specific Stability of Ester Linkages in ADCs
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The proposed method for releasing alcoholcontaining payloads is to introduce a selfimmolating spacer that will spontaneously
cyclize following lysosomal cleavage of the
amide bond of the citrulline.

Mouse Plasma

Questions
1.1 Can we4/13/20
make a linker that couples via an ester in order to deliver alcohol containing payloads?
2. Is the drug delivered to the cell and does it work?

The stability of the ester containing ADCs is dependent on the site at which it is conjugated.
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